- Home
- BMRC vs BNTC Comparison
BMRC vs BNTC Comparison
Compare BMRC & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRC
- BNTC
- Stock Information
- Founded
- BMRC 1989
- BNTC 1995
- Country
- BMRC United States
- BNTC United States
- Employees
- BMRC N/A
- BNTC N/A
- Industry
- BMRC Major Banks
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- BMRC Finance
- BNTC Health Care
- Exchange
- BMRC Nasdaq
- BNTC Nasdaq
- Market Cap
- BMRC 365.9M
- BNTC 365.1M
- IPO Year
- BMRC N/A
- BNTC N/A
- Fundamental
- Price
- BMRC $24.37
- BNTC $13.70
- Analyst Decision
- BMRC Buy
- BNTC Strong Buy
- Analyst Count
- BMRC 4
- BNTC 5
- Target Price
- BMRC $26.25
- BNTC $26.00
- AVG Volume (30 Days)
- BMRC 77.2K
- BNTC 36.4K
- Earning Date
- BMRC 10-27-2025
- BNTC 11-13-2025
- Dividend Yield
- BMRC 4.05%
- BNTC N/A
- EPS Growth
- BMRC N/A
- BNTC N/A
- EPS
- BMRC 0.43
- BNTC N/A
- Revenue
- BMRC $93,409,000.00
- BNTC N/A
- Revenue This Year
- BMRC $59.17
- BNTC N/A
- Revenue Next Year
- BMRC $15.96
- BNTC N/A
- P/E Ratio
- BMRC $57.16
- BNTC N/A
- Revenue Growth
- BMRC 59.35
- BNTC N/A
- 52 Week Low
- BMRC $19.11
- BNTC $8.20
- 52 Week High
- BMRC $27.11
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- BMRC 52.60
- BNTC 56.87
- Support Level
- BMRC $23.86
- BNTC $13.30
- Resistance Level
- BMRC $25.45
- BNTC $14.05
- Average True Range (ATR)
- BMRC 0.50
- BNTC 0.55
- MACD
- BMRC 0.01
- BNTC 0.01
- Stochastic Oscillator
- BMRC 32.08
- BNTC 63.53
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties and others. The majority of its revenue comes from interest income.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.